论文部分内容阅读
目的:评价抗生素替换用药对肺部细菌感染控制的疗效,为临床治疗和理论研究提供参考依据。方法:选取2013年3月—2014年3月期间收治的肺部细菌感染的患者60例,将其分为3组(每组20例),即A组(替换前期组)、B组(替换后期组)和C组(常规用药组),针对3组患者用药不同情况作对比分析。结果:A组与B组的疗效优于C组,经肺部细菌感染疗效的分析,其差异有统计学意义(P<0.05)。结论:抗生素替换用药可在一定程度上减少耐药菌的产生,在肺部细菌感染控制中值得临床推广使用。
Objective: To evaluate the efficacy of antibiotic replacement therapy on the control of bacterial infection in the lungs and provide reference for clinical treatment and theoretical research. Methods: Sixty patients with bacterial infection of the lung during March 2013 to March 2014 were selected and divided into three groups (20 in each group), namely group A (replacement group), group B Late group) and C group (conventional drug group), for the three groups of patients for different situations for comparative analysis. Results: The efficacy of group A and B was better than that of group C, and the difference was statistically significant (P <0.05). Conclusion: Antibiotic replacement therapy can reduce the generation of drug-resistant bacteria to a certain extent, which is worthy of clinical promotion and use in the control of pulmonary bacterial infection.